Drug lobby group: Healthcare bill up in air

Wall Street Journal, January 29, 2010

The chairman of the drug industry's main trade group in the U.S. said the group "hasn't withdrawn support" for the version of healthcare reform passed by the Senate, but that the Massachusetts election has "thrown everything up in the air a bit." David Brennan, chief executive of drug company AstraZeneca PLC and the current chairman of Pharmaceutical Research and Manufacturers of America, said "it's difficult to say right now" whether the industry's pledge to forgo $80 billion in revenue over a decade to help reduce healthcare costs will remain in place, the Wall Street Journal reports.


MOST POPULAR

SPONSORED REPORTS
SPONSORED HEADLINES

SIGN UP

FREE e-Newsletters Join the Council Subscribe to HL magazine

SPONSORSHIP & ADVERTISING

100 Winners Circle Suite 300
Brentwood, TN 37027

800-727-5257

About | Advertise | Terms of Use | Privacy Policy | Reprints/Permissions | Contact
© HealthLeaders Media 2015 a division of BLR All rights reserved.